{
    "clinical_study": {
        "@rank": "146370", 
        "arm_group": {
            "arm_group_label": "Specimen Collection/Risk Factor Assessment -> Diet/Exercise ->", 
            "arm_group_type": "Experimental", 
            "description": "Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Chemotherapy"
        }, 
        "brief_summary": {
            "textblock": "This clinical trial studies dietary and exercise interventions in preventing cardiovascular\n      disease in younger survivors of leukemia, lymphoma, or brain tumors. Eating a healthy diet\n      and exercising regularly may reduce the risk in preventing cardiovascular disease in younger\n      survivors of leukemia, lymphoma, or brain tumors."
        }, 
        "brief_title": "Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Childhood Brain Tumor", 
            "Childhood Hodgkin Lymphoma", 
            "Childhood Non-Hodgkin Lymphoma", 
            "Leukemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Brain Neoplasms", 
                "Cardiovascular Diseases", 
                "Hodgkin Disease", 
                "Leukemia", 
                "Lymphoma", 
                "Lymphoma, Non-Hodgkin"
            ]
        }, 
        "detailed_description": {
            "textblock": "To study the effect of lifestyle changes (dietary and physical activity) on cardiovascular\n      risk factors (BMI, Waist circumference and blood pressure) in childhood survivors of\n      leukemia, lymphoma and brain tumors 2. To study whether there is a difference between the\n      response to intervention between the different types of cancers (leukemia vs. lymphoma vs.\n      brain tumors), and to correlate response to disease 3. To determine the feasibility of\n      lifestyle changes in this patient population 4. To assess adherence to changes in dietary\n      and physical activity during the course of this planned intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1. Diagnosis of leukemia, lymphoma, brain tumors\n\n          -  2. At risk and medium risk patient\n\n          -  3. Patients 3 months to 2 year after completion of therapy\n\n        Exclusion Criteria:\n\n          -  1. Patients who are already on antihypertensive or insulin or cholesterol lowering\n             medication.\n\n          -  2. High risk patient, as they will receive pharmaceutical intervention\n\n          -  3. Other cancer diagnoses"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "57", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02000986", 
            "org_study_id": "MCC-14062", 
            "secondary_id": "HM14062"
        }, 
        "intervention": {
            "arm_group_label": "Specimen Collection/Risk Factor Assessment -> Diet/Exercise ->", 
            "description": "Participants will be taught by a registered dietician about energy balance and how body weight relates to energy intake and expenditure, although specific calorie prescriptions will not be given. An exercise physiologist will create a personalized exercise plan and prescription which is tailored to his / her needs and current level of activity and fitness", 
            "intervention_name": "Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Chemotherapy", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hodgkin's Lymphoma", 
            "Brain and Nervous System", 
            "Non-Hodgkin's Lymphoma", 
            "Leukemia, not otherwise specified"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": {
            "contact": {
                "email": "mhelou@vcvh-vcu.edu", 
                "last_name": "Marieka A Helou, MD", 
                "phone": "804-828-9605"
            }, 
            "facility": {
                "address": {
                    "city": "Richmond", 
                    "country": "United States", 
                    "state": "Virginia", 
                    "zip": "23298"
                }, 
                "name": "Virginia Commonwealth University, Massey Cancer Center"
            }, 
            "investigator": {
                "last_name": "Marieka A Helou, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Non-Pharmacologic Interventions on Risk Factors of Cardiovascular Disease in Survivors of Childhood Leukemia, Lymphoma and Brain Tumor", 
        "overall_contact": {
            "email": "mhelou@mcvh-vcu.edu", 
            "last_name": "Marieka A Helou, MD", 
            "phone": "804-828-9605"
        }, 
        "overall_official": {
            "affiliation": "Massey Cancer Center", 
            "last_name": "Marieka A Helou, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Will be assessed via paired T test.", 
            "measure": "Change in weight, defined as a decrease in weight by 5-10% from the enrollment weight", 
            "safety_issue": "No", 
            "time_frame": "Baseline to up to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02000986"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Will be assessed via paired T test.", 
                "measure": "Change in blood pressure, defined as a decrease in systolic blood pressure by 4-8 mmHg from the blood pressure at enrollment", 
                "safety_issue": "No", 
                "time_frame": "Baseline to up to 60 months"
            }, 
            {
                "description": "Will be assessed via paired T test.", 
                "measure": "Change in total cholesterol, defined as a decrease in total cholesterol by 5-7% from the level at time of enrollment", 
                "safety_issue": "No", 
                "time_frame": "Baseline to up to  months"
            }
        ], 
        "source": "Virginia Commonwealth University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Virginia Commonwealth University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}